Here's proof that bowel cancer screening reduces deaths

September 19, 2019

New research led by the University of South Australia shows just how effective bowel cancer screening is in helping to reduce the number of bowel cancer deaths by up to 45 per cent.

Bowel (or colorectal) cancer kills almost 6000 people in Australia each year and 700,000 worldwide but this number would be much higher without pre-diagnostic colonoscopies, a study has found.

Data from 12,906 bowel cancer patients indicate that faecal occult blood testing (FOBT) with a follow-up colonoscopy plays a key role in catching the disease early, before symptoms appear.

Researchers from UniSA's Cancer Epidemiology and Population Health found that having one pre-diagnostic colonoscopy was associated with a 17 per cent reduction in cancer deaths; a 27 per cent reduction with two pre-diagnostic colonoscopy procedures and 45 per cent for three or more.

Of the 12,906 records analysed, 37 per cent of the patients had pre-diagnostic colonoscopies and were more likely to live longer than those who were diagnosed after experiencing cancer symptoms.

Dr Ming Li, one of the study leaders, says that in South Australia, where the study was undertaken, those patients who had pre-diagnostic colonoscopies showed a "significant increase" in survival.

The risk of colorectal cancer death reduces step-wise with increasing numbers of colonoscopy examinations before symptoms appear, cutting the mortality rate from 17 per cent to 45 per cent," she says.

"Our findings show the value of the National Bowel Screening Program which is now being rolled out to everyone in Australia over the age of 50 on a two-yearly basis. It involves doing a simple, non-invasive faecal occult blood test (FOBT) which, if positive, is followed up with a colonoscopy."

Bowel cancer causes the second highest number of cancer deaths in Australia after lung cancer, and is the third most common cancer worldwide, but 90 per cent can be cured if detected early, according to the Cancer Council.

Currently, just 39 per cent of the eligible population in Australia undertake a FOBT if invited, which is predicted to prevent 92,000 cancer cases in the next 20 years. If the participation rate were to increase to 60 per cent, an additional 24,300 bowel cancer deaths would be prevented, the Cancer Council estimates.
-end-
The study has been published in BMC Cancer.

University of South Australia

Related Colonoscopy Articles from Brightsurf:

Using robotic assistance to make colonoscopy kinder and easier
Scientists have made a breakthrough in their work to develop semi-autonomous colonoscopy, using a robot to guide a medical device into the body.

Nearly 1 in 8 patients receive unexpected out-of-network bills after colonoscopy
Nearly 1 in 8 commercially insured patients nationwide who underwent an elective colonoscopy between 2012 and 2017 performed by an in-network provider received potential 'surprise' bills for out-of-network expenses, often totaling hundreds of dollars or more.

Swallowing this colonoscopy-like bacteria grabber could reveal secrets about your health
Your gut bacteria could say a lot about you, such as why you're diabetic or how you respond to certain drugs.

Examining association between older age, risk of complications after colonoscopy
This observational study looked at the risk of complications after an outpatient colonoscopy among patients age 75 and older compared to younger patients.

Bowel cancer rates after colonoscopy vary by provider
A colonoscopy is the main test used to detect bowel cancer, but like most tests, it is not always 100% accurate and cancers can be missed.

Will disposable colonoscopy devices replace reusables?
As a disposable version of the instrument used in one of the most common medical procedures in the United States inches closer to widespread availability, a team of Johns Hopkins data researchers is studying the economic and safety implications associated with the devices used to perform colonoscopies.

Sedation method does not affect colonoscopy detection rate
Colon cancer is the second leading cause of cancer death in the United States and colonoscopy is the most-used screening tool to detect it.

Blue dye tablet helps identify polyps during colonoscopy
Ingestion of a blue dye tablet during bowel prep for colonoscopy could be a significant advance in the early detection of colorectal cancer (CRC).

Low complication rates after screening colonoscopy
During colonoscopy screening for bowel cancer and in the four weeks after the procedure, the risk for complications to develop is low.

Patients with positive fecal screening test, sooner is better for colonoscopy
The risk of colorectal cancer increased significantly when colonoscopy was delayed by more than nine months following a positive fecal screening test, according to a large Kaiser Permanente study published today in the Journal of the American Medical Association.

Read More: Colonoscopy News and Colonoscopy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.